GlaxoSmithKline (GSK)

Add to Watchlists Create an Alert
50.01 -0.03  -0.06% NYSE Jul 24, 11:22AM BATS Real time Currency in USD

GlaxoSmithKline Net Income (TTM):

8.198B for March 31, 2014

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Net Income (TTM) Chart

Export Data
Save Image

GlaxoSmithKline Historical Net Income (TTM) Data

View and export this data going back to 1985. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
March 31, 2014 8.198B
Dec. 31, 2013 8.585B
Sept. 30, 2013 5.962B
June 30, 2013 6.205B
March 31, 2013 6.559B
Dec. 31, 2012 7.120B
Sept. 30, 2012 7.725B
June 30, 2012 8.199B
March 31, 2012 8.044B
Dec. 31, 2011 8.429B
Sept. 30, 2011 5.371B
June 30, 2011 5.149B
March 31, 2011 2.892B
Dec. 31, 2010 2.543B
Sept. 30, 2010 6.295B
June 30, 2010 6.488B
March 31, 2010 9.161B
Dec. 31, 2009 8.697B
Sept. 30, 2009 7.572B
June 30, 2009 7.322B
March 31, 2009 7.639B
Dec. 31, 2008 8.599B
Sept. 30, 2008 9.235B
June 30, 2008 9.943B
March 31, 2008 10.05B
   
Dec. 31, 2007 10.43B
Sept. 30, 2007 10.52B
June 30, 2007 10.48B
March 31, 2007 10.23B
Dec. 31, 2006 9.903B
Sept. 30, 2006 9.604B
June 30, 2006 9.148B
March 31, 2006 8.949B
Dec. 31, 2005 8.594B
Sept. 30, 2005 8.069B
June 30, 2005 7.752B
March 31, 2005 7.637B
Dec. 31, 2004 7.414B
Sept. 30, 2004 7.493B
June 30, 2004 7.488B
March 31, 2004 7.511B
Dec. 31, 2003 7.400B
Sept. 30, 2003 7.631B
June 30, 2003 7.020B
March 31, 2003 6.729B
Dec. 31, 2002 6.255B
Sept. 30, 2002 5.936B
June 30, 2002 5.263B
March 31, 2002 5.181B
Dec. 31, 2001 4.737B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Net Income

Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.

Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More

Get data for
Advertisement

GSK Net Income (TTM) Benchmarks

Companies
AstraZeneca 2.049B
Pfizer 21.58B
Novartis 9.757B

GSK Net Income (TTM) Range, Past 5 Years

Minimum 2.543B Dec 2010
Maximum 9.161B Mar 2010
Average 6.800B

GSK Net Income (TTM) Excel Add-In Codes

  • Metric Code: net_income_ttm
  • Latest data point: =YCP("GSK", "net_income_ttm")
  • Last 5 data points: =YCS("GSK", "net_income_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.